Submit Deal

Submit Deal

Announced

29 Sep 2023

Completed

18 Apr 2024

Cinven completed the acquisition of a 42.6% stake in Synlab for €1.2bn.

Synopsis

Cinven, a private equity firm, completed the acquisition of of a 42.6% stake in Synlab, an international medical diagnostics provider headquartered in Munich, Germany, for €1.2bn. Cinven and SYNLAB AG have signed an investment agreement backing the long-term strategy of the company.

Principals

target

Synlab

bidder

Cinven

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Dealmakers (22)

Service Providers

Sort

Cai Berg

Financial AdvisorSenior Managing Director at ParkView Partners

Mathieu Floreani

ManagerCEO at SYNLAB AG

Sami Badarani

ManagerCFO at SYNLAB AG

Wilhelm Reinhardt

Advisor LawyerPartner at Gibson Dunn & Crutcher

Sung-Duk Kim

Financial AdvisorManaging Director and Head of M&A Germany at Macquarie Group

Fabian Truebenbach

Financial AdvisorManaging Director at Macquarie Group

Ben Leyendecker

LawyerPartner at Kirkland & Ellis

Shahrzad Sadjadi

LawyerAssociate at Kirkland & Ellis

Friedrich Focke

LawyerAssociate at Kirkland & Ellis

Sebastian Häfele

LawyerPartner at Kirkland & Ellis

Christoph Jerger

LawyerPartner at Kirkland & Ellis

Philip Goj

LawyerPartner at Kirkland & Ellis

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.